Published by mark itwired
Posted on September 16, 2021
8 min readLast updated: February 9, 2026
Add as preferred source on Google
Introduction of upgraded and highly precise lacrimal duct stent tube for canalicular stenosis or obstruction and congenital nasolacrimal duct obstruction remains a key booster to the growth of lacrimal duct stent tube market. The global market for lacrimal duct stent tube is projected for a promising 6% CAGR during 2019 – 2029, as suggested by a new Future Market Insights (FMI) report.
There has been higher preference for bicanalicular lacrimal duct stent tube over its monocanalicular counterpart, attributing to the former’s high success rate, suitability for stenting in older patients, and better clinical outcomes. Moreover, increasing prevalence of retina-related conditions, primarily imperforation of nasolacrimal duct, epiphora both in infants and adults, and conditions necessitating dacryocystorhinostomy are other factors responsible for propelling revenue growth of the lacrimal duct stent tube market.
Consistent efforts towards diagnosis and management of lacrimal duct obstruction with enhanced success rate, minimally invasive lacrimal surgery, and better clinical outcomes, and increasing product awareness among ophthalmologist are factors augmenting growth prospects for the lacrimal duct stent tube market.
Request For Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9649
Numerous organizations are focusing on new product development for lacrimal duct stent tube. In June 2019, FCI Ophthalmic offered a complete line of BIKA stents namely, BIKA, BIKA for DCR, and Infant BIKA covering a range of sizes that will benefit most of the congenital nasolacrimal duct obstruction (CNLDO) and dacryocystorhinostomy (DCR) cases.
Future Market Insights brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each segment from 2014 to 2029. The global lacrimal duct stent tube market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on lacrimal duct stent tube market on basis of product type (monocanalicular lacrimal duct stent tube, bicanalicular lacrimal duct stent tube), and end user (hospitals, ophthalmic clinics, ambulatory surgical centers), across seven major regions.
Download Report TOC @ https://www.futuremarketinsights.com/reports/lacrimal-devices-market/table-of-content
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3.1. Key Trends Impacting the Market
4.1. Global Lacrimal Duct Stent Tube Market – Pricing Analysis
4.1.1. Regional Pricing Analysis By Product Type
4.1.2. Global Average Pricing Analysis Benchmark
4.2. Epidemiology of Nasolacrimal Obstruction, By Country
5.1. Historical Market Analysis, 2014-2018
5.2. Current and Future Market Projections, 2019-2029
5.3. Y-o-Y Growth Trend Analysis
6.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
6.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7.1. Macro-Economic Factors
7.2. Forecast Factors – Relevance & Impact
7.3. Market Dynamics
7.3.1. Drivers
7.3.2. Restraints
7.3.3. Opportunity Analysis
The post Lacrimal Duct Stent Tube Market Segmentation, Industry Analysis 2029 first appeared on Market Research Blog.
Introduction of upgraded and highly precise lacrimal duct stent tube for canalicular stenosis or obstruction and congenital nasolacrimal duct obstruction remains a key booster to the growth of lacrimal duct stent tube market. The global market for lacrimal duct stent tube is projected for a promising 6% CAGR during 2019 – 2029, as suggested by a new Future Market Insights (FMI) report.
There has been higher preference for bicanalicular lacrimal duct stent tube over its monocanalicular counterpart, attributing to the former’s high success rate, suitability for stenting in older patients, and better clinical outcomes. Moreover, increasing prevalence of retina-related conditions, primarily imperforation of nasolacrimal duct, epiphora both in infants and adults, and conditions necessitating dacryocystorhinostomy are other factors responsible for propelling revenue growth of the lacrimal duct stent tube market.
Consistent efforts towards diagnosis and management of lacrimal duct obstruction with enhanced success rate, minimally invasive lacrimal surgery, and better clinical outcomes, and increasing product awareness among ophthalmologist are factors augmenting growth prospects for the lacrimal duct stent tube market.
Request For Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9649
Numerous organizations are focusing on new product development for lacrimal duct stent tube. In June 2019, FCI Ophthalmic offered a complete line of BIKA stents namely, BIKA, BIKA for DCR, and Infant BIKA covering a range of sizes that will benefit most of the congenital nasolacrimal duct obstruction (CNLDO) and dacryocystorhinostomy (DCR) cases.
Future Market Insights brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each segment from 2014 to 2029. The global lacrimal duct stent tube market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on lacrimal duct stent tube market on basis of product type (monocanalicular lacrimal duct stent tube, bicanalicular lacrimal duct stent tube), and end user (hospitals, ophthalmic clinics, ambulatory surgical centers), across seven major regions.
Download Report TOC @ https://www.futuremarketinsights.com/reports/lacrimal-devices-market/table-of-content
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3.1. Key Trends Impacting the Market
4.1. Global Lacrimal Duct Stent Tube Market – Pricing Analysis
4.1.1. Regional Pricing Analysis By Product Type
4.1.2. Global Average Pricing Analysis Benchmark
4.2. Epidemiology of Nasolacrimal Obstruction, By Country
5.1. Historical Market Analysis, 2014-2018
5.2. Current and Future Market Projections, 2019-2029
5.3. Y-o-Y Growth Trend Analysis
6.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
6.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7.1. Macro-Economic Factors
7.2. Forecast Factors – Relevance & Impact
7.3. Market Dynamics
7.3.1. Drivers
7.3.2. Restraints
7.3.3. Opportunity Analysis
The post Lacrimal Duct Stent Tube Market Segmentation, Industry Analysis 2029 first appeared on Market Research Blog.
Canalicular stenosis is a condition where the tear ducts become narrowed or blocked, leading to excessive tearing and potential infections.
Dacryocystorhinostomy is a surgical procedure to create a new drainage pathway for tears from the lacrimal sac into the nasal cavity, often used to treat blocked tear ducts.
A bicanalicular stent is a type of stent designed to be placed in both tear ducts, providing a higher success rate in treating obstructions compared to monocanalicular stents.
Clinical outcomes of lacrimal duct stenting include improved tear drainage, reduced symptoms of epiphora, and enhanced quality of life for patients with tear duct obstructions.
Explore more articles in the Research Reports category
